Best Thing I Ate: Too Good to Be Stew
Treat Your Feelings: We Have the Perfect Baked-Good Solution for Any Problem
Back to Hydra: Revisiting the Scene of One of Vanmag’s Most Controversial Reviews
Wine List: The Best Italian Wines to Try at Vancouver International Wine Fest
Find an Excuse to Celebrate, Because These Sparkling Wines Are the Best in the Fizz
Editors’ Picks: The Best Things We Drank in 2023
City Informer: Why Is a Hummingbird the Official City Bird of Vancouver?
5 Things to Do in Vancouver This Week (February 26- March 3)
Your forever home. Your forever fund.
Escape to Osoyoos: Your Winter Wonderland Awaits
Your 2023/2024 Ultimate Local Winter Getaway Guide
Kamloops Unscripted: The Most Intriguing Fall Destination of 2023
Protected: Experience Kitchen Brilliance: Unveiling the Ultimate Culinary Workstation
Vancouver-Based Fashion Brand Ization Studio Brings the Fun
7 Stylish, Statement-Making Jackets for Spring
Young-blood therapy—“parabiosis”—works in mice, no question about it. Multiple experiments conducted at Harvard and elsewhere within the last five years have found that blood transfused from young mice into old ones had a rejuvenating effect. The old mice grew peppier. They performed better on memory tests. Their fur grew sleek and lustrous. Something in that new, rich plasma was healing and repairing aging organs by activating dormant stem cells. No one knows which among hundreds of goodies in the young blood—circulating proteins, growth factors, immune-system boosters—might be responsible, or whether whatever mechanism is at work could also work in humans.
But that hasn’t stopped research from moving to the human-experiment stage. If you’re over 35 you can be part of a clinical trial run by the U.S. National Institute of Health and receive blood from a donor between 16 and 25 years old to see if and how it spruces you up. In a separate study going on at Stanford, Alzheimer’s patients receive young-blood transfusions to see if it stems cognitive decline. The endgame is to isolate the magic active ingredient in the blood serum and sell it in a pill.
There’s a what’s-old-is-new-again dimension in all this. The idea of young blood as an elixir goes back to ancient Greece. The difference now is the potential customer. It used to be the poor, who, unable to procure expensive medicine, would slip the executioner a few pennies for a cup of blood. Now only the rich, such as PayPal founder and Trump booster Peter Thiel, can afford to roll the dice on this life hack. The NIH trial, sponsored by the Monterey-based company Ambrosia LLC, costs $8,000 (U.S.) to participate in.
Check back for more from VanMag‘s 25 Ways to Live Forever package (our March 2017 cover story!) to learn about the myriad ways Vancouverites chase the dream of eternal youth.